These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 18343923)
1. Gamma-IFN-inducible-lysosomal thiol reductase modulates acidic proteases and HLA class II antigen processing in melanoma. Goldstein OG; Hajiaghamohseni LM; Amria S; Sundaram K; Reddy SV; Haque A Cancer Immunol Immunother; 2008 Oct; 57(10):1461-70. PubMed ID: 18343923 [TBL] [Abstract][Full Text] [Related]
2. High GILT Expression and an Active and Intact MHC Class II Antigen Presentation Pathway Are Associated with Improved Survival in Melanoma. Buetow KH; Meador LR; Menon H; Lu YK; Brill J; Cui H; Roe DJ; DiCaudo DJ; Hastings KT J Immunol; 2019 Nov; 203(10):2577-2587. PubMed ID: 31591149 [TBL] [Abstract][Full Text] [Related]
3. GILT in Thymic Epithelial Cells Facilitates Central CD4 T Cell Tolerance to a Tissue-Restricted, Melanoma-Associated Self-Antigen. Rausch MP; Meador LR; Metzger TC; Li H; Qiu S; Anderson MS; Hastings KT J Immunol; 2020 Jun; 204(11):2877-2886. PubMed ID: 32269095 [TBL] [Abstract][Full Text] [Related]
4. GILT Expression in Human Melanoma Cells Enhances Generation of Antigenic Peptides for HLA Class II-Mediated Immune Recognition. Hathaway-Schrader JD; Norton D; Hastings K; Doonan BP; Fritz ST; Bethard JR; Blum JS; Haque A Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35162988 [TBL] [Abstract][Full Text] [Related]
5. Gamma-interferon-inducible lysosomal thiol reductase is upregulated in human melanoma. Nguyen J; Bernert R; In K; Kang P; Sebastiao N; Hu C; Hastings KT Melanoma Res; 2016 Apr; 26(2):125-37. PubMed ID: 26930048 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of acid ceramidase regulates MHC class II antigen presentation and suppression of autoimmune arthritis. Zhao D; Hajiaghamohseni LM; Liu X; Szulc ZM; Bai A; Bielawska A; Norris JS; Reddy SV; Hannun YA; Haque A Cytokine; 2020 Nov; 135():155219. PubMed ID: 32738771 [TBL] [Abstract][Full Text] [Related]
7. Functional requirements for the lysosomal thiol reductase GILT in MHC class II-restricted antigen processing. Hastings KT; Lackman RL; Cresswell P J Immunol; 2006 Dec; 177(12):8569-77. PubMed ID: 17142755 [TBL] [Abstract][Full Text] [Related]
8. Cutting edge: induction of the antigen-processing enzyme IFN-gamma-inducible lysosomal thiol reductase in melanoma cells Is STAT1-dependent but CIITA-independent. O'Donnell PW; Haque A; Klemsz MJ; Kaplan MH; Blum JS J Immunol; 2004 Jul; 173(2):731-5. PubMed ID: 15240658 [TBL] [Abstract][Full Text] [Related]
9. Endogenous HLA class II epitopes that are immunogenic in vivo show distinct behavior toward HLA-DM and its natural inhibitor HLA-DO. Kremer AN; van der Meijden ED; Honders MW; Goeman JJ; Wiertz EJ; Falkenburg JH; Griffioen M Blood; 2012 Oct; 120(16):3246-55. PubMed ID: 22889757 [TBL] [Abstract][Full Text] [Related]
10. Diverse cellular and organismal functions of the lysosomal thiol reductase GILT. Rausch MP; Hastings KT Mol Immunol; 2015 Dec; 68(2 Pt A):124-8. PubMed ID: 26116226 [TBL] [Abstract][Full Text] [Related]
11. GILT modulates CD4+ T-cell tolerance to the melanocyte differentiation antigen tyrosinase-related protein 1. Rausch MP; Hastings KT J Invest Dermatol; 2012 Jan; 132(1):154-62. PubMed ID: 21833020 [TBL] [Abstract][Full Text] [Related]
12. GILT accelerates autoimmunity to the melanoma antigen tyrosinase-related protein 1. Rausch MP; Irvine KR; Antony PA; Restifo NP; Cresswell P; Hastings KT J Immunol; 2010 Sep; 185(5):2828-35. PubMed ID: 20668223 [TBL] [Abstract][Full Text] [Related]
14. GILT expression in B cells diminishes cathepsin S steady-state protein expression and activity. Phipps-Yonas H; Semik V; Hastings KT Eur J Immunol; 2013 Jan; 43(1):65-74. PubMed ID: 23012103 [TBL] [Abstract][Full Text] [Related]
15. Cathepsin S regulates class II MHC processing in human CD4+ HLA-DR+ T cells. Costantino CM; Ploegh HL; Hafler DA J Immunol; 2009 Jul; 183(2):945-52. PubMed ID: 19553543 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms regulating enhanced human leukocyte antigen class II-mediated CD4 + T cell recognition of human B-cell lymphoma by resveratrol. Radwan FF; Zhang L; Hossain A; Doonan BP; God JM; Haque A Leuk Lymphoma; 2012 Feb; 53(2):305-14. PubMed ID: 21854084 [TBL] [Abstract][Full Text] [Related]
17. Heat shock protein 90-mediated peptide-selective presentation of cytosolic tumor antigen for direct recognition of tumors by CD4(+) T cells. Tsuji T; Matsuzaki J; Caballero OL; Jungbluth AA; Ritter G; Odunsi K; Old LJ; Gnjatic S J Immunol; 2012 Apr; 188(8):3851-8. PubMed ID: 22427632 [TBL] [Abstract][Full Text] [Related]
18. Enhancement of HLA class II-restricted CD4+ T cell recognition of human melanoma cells following treatment with bryostatin-1. Zhao D; Amria S; Hossain A; Sundaram K; Komlosi P; Nagarkatti M; Haque A Cell Immunol; 2011; 271(2):392-400. PubMed ID: 21903207 [TBL] [Abstract][Full Text] [Related]
19. MHC class II-restricted presentation of the major house dust mite allergen Der p 1 Is GILT-dependent: implications for allergic asthma. West LC; Grotzke JE; Cresswell P PLoS One; 2013; 8(1):e51343. PubMed ID: 23326313 [TBL] [Abstract][Full Text] [Related]
20. Insights into the Role of GILT in HLA Class II Antigen Processing and Presentation by Melanoma. Norton DL; Haque A J Oncol; 2009; 2009():142959. PubMed ID: 20016802 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]